Clinical trial

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

NCT02269982

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-05-14

PhaseN/A

Study timeline

Study start (actual)2015-05-14Date precision: day

Registry last updated2019-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

AR-v7 assaysDEVICE

Sponsors & collaborators

Duke Universitylead sponsor

Weill Medical College of Cornell Universitycollaborator

Johns Hopkins Universitycollaborator

Dana-Farber Cancer Institutecollaborator

Memorial Sloan Kettering Cancer Centercollaborator

Epic Sciencescollaborator

Prostate Cancer Foundationcollaborator

Mapped research locations

New YorkNew York, United States2 ChicagoIllinois, United States1 BaltimoreMaryland, United States1 DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02269982 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.